Here is what each format involves, how it is used, and what distinguishes it from the alternatives.
Oral Pills
Oral estrogen has been in clinical use the longest and remains one of the most familiar formats. Pills are taken daily by mouth and absorbed through the digestive tract before entering the bloodstream.
The defining characteristic of oral estrogen is that it passes through the liver before circulating throughout the body. This first-pass hepatic metabolism has several clinical consequences:
- Oral estrogen increases levels of clotting proteins in the liver, raising the risk of venous thromboembolism compared to transdermal options
- It can elevate triglyceride levels in some women
- It may increase thyroid-binding globulin, which can affect dosing for women who also take thyroid medication
- Oral pills are convenient, taken on a simple daily schedule, and well studied for effectiveness
For women without elevated cardiovascular risk, oral pills remain a clinically sound option. For women who smoke, have a history of migraines with aura, or carry other vascular risk factors, transdermal formats are generally considered more appropriate.
Transdermal Patches
Patches are applied directly to the skin, typically on the lower abdomen, buttocks, or upper arm, and deliver estrogen through the skin into the bloodstream. Depending on the formulation, they are replaced once or twice per week.
According to StatPearls via the National Institutes of Health, transdermal estrogen bypasses liver metabolism entirely, which eliminates the increase in clotting protein production associated with oral estrogen. This makes patches a preferable option for women with elevated clotting risk, migraines, or a history of cardiovascular concerns.
Key points about transdermal patches:
- Deliver a steady, consistent dose of hormones over several days
- Do not significantly affect triglycerides or thyroid-binding globulin at standard doses
- Carry a neutral effect on blood lipids compared to oral formulations
- May cause skin irritation or adhesion issues in some women, particularly in humid conditions
- Some women find it difficult to keep patches adhered during exercise or swimming
Topical Creams and Gels
Estrogen creams and gels are applied to the skin daily, typically on the arms, shoulders, or thighs. Like patches, they deliver hormones transdermally, bypassing the liver and avoiding the clotting risks associated with oral estrogen.
The key difference between creams or gels and patches is the delivery mechanism. Patches release a controlled dose through a membrane over several days. Creams and gels are absorbed more variably depending on the application site, the amount applied, and individual skin characteristics.
Practical considerations for creams and gels:
- Must be applied to clean, dry skin and allowed to dry completely before contact with others
- Application site should not be washed for several hours after use
- Dose consistency depends heavily on the user applying the correct amount each day
- Generally well tolerated and carry a lower skin irritation profile than patches
Vaginal Creams and Rings
Vaginal estrogen is a local rather than systemic delivery method. It is applied directly to vaginal tissue in low doses and is used specifically for genitourinary syndrome of menopause, which includes symptoms like vaginal dryness, itching, burning, and urinary discomfort.
Because so little estrogen enters the bloodstream from vaginal applications, the systemic risks associated with other delivery methods are significantly reduced. Vaginal estrogen does not effectively treat systemic symptoms like hot flashes or mood changes.
Options include:
- Vaginal creams applied with an applicator several times per week
- A low-dose estradiol ring inserted into the vagina and replaced every three months
- Vaginal tablets or soft gel inserts placed directly into the vaginal canal
Subcutaneous Pellets
Pellet therapy involves small, compounded hormone pellets inserted under the skin, typically in the hip or buttock area, by a healthcare provider during a brief in-office procedure. The pellets dissolve slowly over several months, releasing hormones gradually into the bloodstream.
Key points about pellet therapy:
- Delivers a continuous, consistent hormone level without daily or weekly application requirements
- Requires a new insertion procedure every three to six months
- Compounded pellets are not FDA-approved, and major professional organizations including the Menopause Society and ACOG do not currently recommend compounded hormone formulations due to limited safety and efficacy data
- FDA-approved subcutaneous implants are under development but not yet widely available
Sprays
Transdermal estrogen sprays are applied directly to the skin, typically on the inner forearm, and absorbed through the skin similarly to gels. They represent a newer and less widely used format but offer convenience and consistent dosing through a metered pump.
Key considerations for sprays:
- Applied once daily to a defined skin area
- Dry time required before contact with clothing or other individuals
- Carry the same liver-bypass benefits as other transdermal methods